OverviewChartTechnicalNewsTraderScreen

Zai Lab Ltd/  US98887Q1040  /

NASDAQ
2024-04-19  9:20:22 PM Chg. -0.0100 Volume Bid9:21:05 PM Ask9:21:05 PM High Low
14.2100USD -0.07% 174,196
Turnover: 1.88 mill.		 14.2000Bid Size: 600 14.2300Ask Size: 200 14.2300 13.9300
GlobeNewswire 04-18 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire 04-10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 03-06 Crescendo Biologics to present at the 2024 AACR Annual Meeting
GlobeNewswire 03-05 Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of...
GlobeNewswire 02-29 argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire 02-14 Genmab Publishes 2023 Annual Report
GlobeNewswire 01-16 Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire 01-08 argenx Highlights 2024 Strategic Priorities
GlobeNewswire 01-04 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 2023-12-13 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire 2023-12-06 Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307...
GlobeNewswire 2023-11-07 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 2023-10-31 argenx Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-10-26 Zai Lab Announces Participation in November Investor Conferences
GlobeNewswire 2023-10-18 Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire 2023-10-05 Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
GlobeNewswire 2023-09-21 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire 2023-09-18 Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and No...
GlobeNewswire 2023-09-18 Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injec...
GlobeNewswire 2023-09-12 Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockh...
GlobeNewswire 2023-09-07 Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR...
GlobeNewswire 2023-09-04 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 2023-08-30 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patien...
GlobeNewswire 2023-08-29 Zai Lab Announces Participation in September Investor Conferences
GlobeNewswire 2022-03-23 Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on Marc...